About BioTranex
BioTranex is a Healthcare company based in Monmouth Junction (United States) founded in 2009, and was acquired by Frontage Laboratories in April 2020. It operates as a DMPK and analytical services are offered via hepatocyte-based platforms. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In Vitro Assays. Its competitors include Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
BioTranex is a preclinical CRO offering comprehensive solutions for DMPK and toxicity testing to drug developers. Their service portfolio includes ADME and DMPK studies, PKPD studies, drug-drug interactions, metabolite interaction studies, human hepatocyte based studies (CYP inhibition and hepatotoxicity studies) and transporter studies. They have special expertise in transporter studies through which they offer patent pending assays namely BSEPcyte (bile salt export pump) and MDR3cyte, which are hepatocyte based platforms which measure the test agent inhibition of BSEP and MDR3.
- Headquarters Monmouth Junction, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biotranex.com
- Social LinkedIn
- Acquired by Frontage Laboratories (Apr 2020)
- Investors
- Acquired byFrontage Laboratories
(Apr 2020)
Investors in BioTranex
BioTranex has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early drug development services are provided for pharma firms. | 2001 | frontagelab.com | Exton, United States |
Investor details for BioTranex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioTranex
2 dated milestones of BioTranex across 11 years, from founding to its latest funding, stage changes and deals.
- Founded BioTranex is founded.
- Exit Acquired by Frontage Laboratories.
Competitors of BioTranex
BioTranex has 10 listed competitors in our database, 6 of them funded. They include Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anabios.com | 2009 | San Diego, United States | $24.78M | 51 | Ex-vivo human tissue studies are performed for preclinical drug discovery. | |
| clydebio.com | 2012 | Holytown, United Kingdom | $3.5M | 6 | Cardiac safety testing is conducted using iPS-derived heart cells. | |
| metrionbiosciences.com | 2015 | Cambridge, United Kingdom | $8.44M | – | Ion channel screening and cardiac safety profiling services are provided. | |
| quiverbioscience.com | 2013 | Cambridge, United States | – | – | Developer of transformational medicines for neurological disorders | |
| zen-bio.com | 1995 | Durham, United States | – | – | Cell-based solutions are provided to accelerate therapy discovery and development. | |
| rulesbasedmedicine.com | 2002 | Austin, United States | $25M | – | Multiplexed immunoassays for protein biomarkers are developed via proprietary platform. | |
| antibodyanalytics.com | 2015 | Lanark, United Kingdom | – | 60 | Antibody analytics and characterization services are provided. | |
| pelagobio.com | 2013 | Solna, Sweden | – | – | Drug-target interactions are quantified via specialized assay services. | |
| eviagenics.com | 2004 | Paris, France | $2.3M | – | Seaweed extract ingredients for food and cosmetics are produced. | |
| biopta.com | 2002 | Godalming, United Kingdom | $1.57M | – | Fresh human tissues are utilized in drug development research. |
Detailed competitors of BioTranex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as BioTranex (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioTranex
BioTranex was founded in 2009.
BioTranex is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
BioTranex is a preclinical CRO offering comprehensive solutions for DMPK and toxicity testing to drug developers. Their service portfolio includes ADME and DMPK studies, PKPD studies, drug-drug interactions, metabolite interaction studies, human hepatocyte based studies (CYP inhibition and hepatotoxicity studies) and transporter studies. They have special expertise in transporter studies through which they offer patent pending assays namely BSEPcyte (bile salt export pump) and MDR3cyte, which are hepatocyte based platforms which measure the test agent inhibition of BSEP and MDR3.
BioTranex's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
BioTranex has 1 investor. Key investors include Frontage Laboratories.
Yes. BioTranex was acquired by Frontage Laboratories in April 2020.